| | | Deletion (frameshift variant +2 more) | Fanconi anemia complementation group D1 +1 more | |
| | | Duplication (frameshift variant) | Fanconi anemia complementation group D1 | |
| | | Microsatellite (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 +8 more | |
| | | Single nucleotide variant (nonsense) | Fanconi anemia complementation group D1 +1 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Medulloblastoma +8 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Fanconi anemia complementation group D1 +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Fanconi anemia complementation group D1 +1 more | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Breast-ovarian cancer, familial, susceptibility to, 2 +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group D1 +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Fanconi anemia complementation group D1 +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Fanconi anemia complementation group D1 +1 more | |
| | | Single nucleotide variant (synonymous variant) | Hereditary breast ovarian cancer syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Breast-ovarian cancer, familial, susceptibility to, 2 +9 more | GConflicting classifications of pathogenicity |
| | | Deletion (frameshift variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (splice donor variant) | Fanconi anemia complementation group D1 +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not specified +9 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | Fanconi anemia complementation group D1 +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (nonsense) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Duplication (frameshift variant) | Hereditary cancer-predisposing syndrome +10 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Hereditary breast ovarian cancer syndrome +9 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Hereditary breast ovarian cancer syndrome +4 more | |
| | | Deletion (frameshift variant) | Fanconi anemia complementation group D1 | |
| | | Single nucleotide variant (missense variant) | Familial cancer of breast +8 more | |
| | | Single nucleotide variant (missense variant) | Hereditary breast ovarian cancer syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Hereditary breast ovarian cancer syndrome +10 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Hereditary breast ovarian cancer syndrome +9 more | GConflicting classifications of pathogenicity |
| | | Deletion (nonsense) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | Hereditary breast ovarian cancer syndrome +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Hereditary breast ovarian cancer syndrome +9 more | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Hereditary breast ovarian cancer syndrome +1 more | |
| | | Single nucleotide variant (missense variant) | not specified +11 more | |
| | | Single nucleotide variant (missense variant) | Hereditary breast ovarian cancer syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +10 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +10 more | |
| | | Single nucleotide variant (missense variant) | Hereditary breast ovarian cancer syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (synonymous variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Deletion (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (missense variant) | Hereditary breast ovarian cancer syndrome +9 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | Hereditary breast ovarian cancer syndrome +10 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | not provided +2 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Fanconi anemia complementation group D1 +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Fanconi anemia complementation group D1 +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Fanconi anemia complementation group D1 +1 more | |
| | | Single nucleotide variant (3 prime UTR variant) | not provided +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (3 prime UTR variant) | Fanconi anemia complementation group D1 +1 more | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | Breast-ovarian cancer, familial, susceptibility to, 2 +1 more | |
| | | Single nucleotide variant (intron variant) | Breast-ovarian cancer, familial, susceptibility to, 2 +1 more | |
| | | Single nucleotide variant (missense variant) | Hereditary breast ovarian cancer syndrome +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (splice acceptor variant) | Breast-ovarian cancer, familial, susceptibility to, 2 +7 more | |
| | | Single nucleotide variant (3 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (3 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Duplication (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Insertion (nonsense) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (intron variant) | not provided +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Fanconi anemia complementation group D1 +2 more | |
| | | Single nucleotide variant (missense variant) | Breast-ovarian cancer, familial, susceptibility to, 2 +10 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Breast-ovarian cancer, familial, susceptibility to, 2 +10 more | |
| | | Single nucleotide variant (missense variant) | Fanconi anemia complementation group D1 +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Breast-ovarian cancer, familial, susceptibility to, 2 +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Breast-ovarian cancer, familial, susceptibility to, 2 +10 more | |
| | | Single nucleotide variant (missense variant) | Wilms tumor 1 +9 more | |
| | | Single nucleotide variant (missense variant) | not provided +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Wilms tumor 1 +11 more | |
| | | Microsatellite (inframe_deletion) | not specified +11 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Hereditary breast ovarian cancer syndrome +11 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +9 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Fanconi anemia complementation group D1 +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Fanconi anemia complementation group D1 +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +11 more | |
| | | Single nucleotide variant (synonymous variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (synonymous variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Deletion (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (missense variant) | Fanconi anemia complementation group D1 +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (synonymous variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (3 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (3 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (3 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (3 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (3 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (5 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (5 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (synonymous variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (missense variant) | not provided +11 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Familial cancer of breast +10 more | GConflicting classifications of pathogenicity |
| | | Duplication (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |